Portage Biotech (CNSX:PTB.U) Lists on Canadian National Stock Exchange - Video News Alert on Investmentpitch.com
October 30, 2013 - London
Vancouver, British Columbia, October 30, 2013 - Portage Biotech (CNSX:PTB.U) (OTCBB:PTGEF) is one of the latest new listings on the Canadian National Stock Exchange, and will trade in US funds. It will continue to trade on the OTCBB.
InvestmentPitch.com has produced a "video news alert" which provides a brief overview of the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Portage" in the search box.
Portage, a British Virgin Islands company, is engaged in researching and developing pharmaceutical and biotech products through to clinical "proof of concept" with an initial focus on unmet clinical needs and orphan drugs.
Following proof of concept, Portage will look to sell or license the products to large pharmaceutical companies for further development and commercialization.
Portage through its subsidiary, Portage Pharmaceuticals Ltd., holds an exclusive worldwide licence in non-oncology fields and the know-how relating to the Antennapedia protein transduction technology developed by Trojantec. Antennapedia ("Antp"), is an unusual protein that allows for the delivery of drugs into a cell and even into the nucleus which is often the desired site of action. This protein coupled with a drug may even cross the blood brain barrier.
Portage is developing a research pipeline of Antp-based drug candidates and evaluating their function and potential as new therapeutic agents for a variety of non-oncology indications.
Portage management is looking to in license additional products to add to its portfolio.
Mr. Kam Shah, CFO commented, "Portage is looking forward to this listing on the CNSX. Listing on this recognized stock exchange will provide additional liquidity to our shareholders, access to larger capital markets, make our shares eligible for tax free savings and RRSP accounts for our Canadian investors and increase our visibility and creditability as a Canadian listed public company."
The company has approximately 176 million shares issued and outstanding, and is showing an opening bid of US$0.23, giving the company a capitalization of US$40.5 million.
For more information, please visit the company's website at www.portagebiotech.com or contact Greg Bailey, Chairman, at 416-929-1806 or by email at email@example.com.
InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases and research reports.
Barry Morgan, CFO
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: InvestmentPitch via Thomson Reuters ONE